TuHURA furnishes investor presentation; merger with Kineta ongoing

TuHURA Biosciences, Inc./NV

Investor presentation used for meetings with investors and analysts starting March 18, 2025.
Presentation discusses proposed merger with Kineta, Inc., but no new deal terms are disclosed.
No new financial or operational data beyond prior SEC filings; content is summary forward-looking information.
Merger completion subject to conditions, including stockholder approvals and financing; risks outlined.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.